These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8344021)

  • 1. The role of thallium scintigraphy in excluding malignancy in bone.
    Van der Wall H; Murray IP; Huckstep RL; Philips RL
    Clin Nucl Med; 1993 Jul; 18(7):551-7. PubMed ID: 8344021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of thallium-201 in the diagnosis of solitary bone lesions.
    Elgazzar AH; Malki AA; Abdel-Dayem HM; Mahmoud A; Sahweil A; Razzak S; Jahan S; el-Sayed M; Omar YT
    Nucl Med Commun; 1989 Jul; 10(7):477-85. PubMed ID: 2797627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors.
    Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Ohkawa M; Tanabe M
    Clin Nucl Med; 2000 Mar; 25(3):200-5. PubMed ID: 10698418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of Thallium-201 scintigraphy in differentiating malignant bone tumors from benign bone lesions.
    Inai R; Shinya T; Tada A; Sato S; Fujiwara T; Takeda K; Kunisada T; Yanai H; Ozaki T; Kanazawa S
    Ann Nucl Med; 2015 Oct; 29(8):674-81. PubMed ID: 26036991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
    J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of thallium-201 scintigraphy in bone and soft tissue tumors.
    Sato O; Kawai A; Ozaki T; Kunisada T; Danura T; Inoue H
    J Orthop Sci; 1998; 3(6):297-303. PubMed ID: 9811980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical usefulness of thallium-201 chloride in the diagnosis of tumor (II)--An evaluation in bone, soft tissue and mediastinal tumors].
    Tonami N; Itoh K; Yui N; Terui S; Torizuka K
    Kaku Igaku; 1994 Jan; 31(1):63-74. PubMed ID: 8309112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone and Tl-201 scintigraphy in a case of hereditary multiple exostoses.
    Tani A; Tsuchimochi S; Nakabeppu Y; Nakajo M
    Clin Nucl Med; 2001 Dec; 26(12):1028-31. PubMed ID: 11711707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radionuclide bone scan as an aid in localizing lesions for bone biopsy.
    Burkhalter JL; Patel BR; Harrison RB
    Skeletal Radiol; 1983; 9(4):246-7. PubMed ID: 6867774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Tc-99m MIBI and Tl-201 uptake in musculoskeletal lesions.
    Adalet I; Ozger H; Cantez S
    Clin Nucl Med; 1996 Feb; 21(2):118-21. PubMed ID: 8697680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
    Goto Y; Ihara K; Kawauchi S; Ohi R; Sasaki K; Kawai S
    J Orthop Sci; 2002; 7(3):304-12. PubMed ID: 12077654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical usefulness of 201Tl-chloride scintigraphy for the evaluation of metastatic bone lesions].
    Fukui A; Kawamura M; Kataoka M; Fujii T; Yamamoto K; Yoshioka S; Ikezoe J
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jan; 58(1):25-33. PubMed ID: 9493430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphic features of nonosteogenic fibroma.
    Brenner RJ; Hattner RS; Lillien DL
    Radiology; 1979 Jun; 131(3):727-30. PubMed ID: 441379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of malignant change in Paget's disease by Tl-201.
    Colarinha P; Fonseca AT; Salgado L; Vieira MR
    Clin Nucl Med; 1996 Apr; 21(4):299-301. PubMed ID: 8925612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors.
    Sumiya H; Taki J; Tsuchiya H; Nonomura A; Miyauchi T; Tonami N
    J Nucl Med; 1998 Sep; 39(9):1600-4. PubMed ID: 9744351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
    Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
    Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma evaluated with 201Tl scintigraphy compared with bone scintigraphy.
    Watanabe N; Shimizu M; Kageyama M; Tanimura K; Kinuya S; Shuke N; Yokoyama K; Tonami N; Watanabe A; Seto H; Goodwin DA
    J Nucl Med; 1999 Jul; 40(7):1138-42. PubMed ID: 10405133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
    Yamamoto Y; Kawaguchi Y; Kawase Y; Maeda Y; Nishiyama Y
    Clin Nucl Med; 2011 Apr; 36(4):290-4. PubMed ID: 21368603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.
    Rosen G; Loren GJ; Brien EW; Ramana L; Waxman A; Lowenbraun S; Eckardt JJ; Eilber F; Menendez L; Mirra JM
    Clin Orthop Relat Res; 1993 Aug; (293):302-6. PubMed ID: 8393392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Appraisal of the clinical value of bone scintigraphy for benign bone tumors and tumor-like lesions].
    Sato Y; Nakayama C; Kimoto T; Nakata H; Suzuki K
    Rinsho Hoshasen; 1987 Jul; 32(7):791-6. PubMed ID: 3682219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.